Search Results 31-40 of 12031 for immunothérapie effets secondaires

1. Mayo Clinic Study Finds Immunotherapy May be Option Challenging Breast Cancer

   Triple negative breast cancer is an aggressive form of breast cancer that evades the immune system because it lacks expression of genes for estrogen receptor, ...

2. Immunotherapy may play role in treating nonmetastatic gastroesophageal cancer - Mayo Clinic News Network

   — Immunotherapy has transformed treatment for patients with stage 4 metastatic esophageal and gastric cancers. In patients with these malignancies, ...

3. Immunotherapy for breast cancer - Doctors & Departments - Mayo Clinic

   Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...

4. A Study Of Obesity And Inflammation Impact Immunotherapy For Renal Cancer - Mayo Clinic

   The purpose of this study is to determine the extent to which immunotherapy failure in kidney cancer patients with obesity is associated with prolonged, body- ...

5. Measuring If Immunotherapy Plus Chemotherapy Is Better Than Chemotherapy Alone For Patients With Aggressive Poorly Differentiated Sarcomas - Mayo Clinic

   The purpose of this study is to assess whether the combination of doxorubicin and pembrolizumab will improve progression free survival (PFS) in UPS and related ...

6. Nivolumab And Ipilimumab In Treating Patients With Esophageal And Gastroesophageal Junction Adenocarcinoma Undergoing Surgery - Mayo Clinic

   Immunotherapy with antibodies, such as nivolumab and ipilimumab, may remove the brake on the body's immune system and may interfere with the ability of ...

7. A Study To Evaluate The Addition Of Immunotherapy Into Adjuvant Therapy For Non-small Cell Lung Cancer - Mayo Clinic

   Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

8. Mayo Clinic researchers identify why some lung tumors respond well to immunotherapy

   ... immunotherapy. A recently approved group of drugs — immune checkpoint ... "Now that we understand how PRKCI is working in a lung tumor, it may be possible to ...

9. Mayo Clinic researchers present advances in immunotherapy, biomarkers and tumor biology at AACR 2026

   Mayo Clinic presents new cancer research at AACR 2026, highlighting advances in immunotherapy, biomarkers and tumor biology.

10. Mayo Clinic researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer

    While immunotherapy continues to advance cancer treatment, not all patients with metastatic colorectal cancer who have a defective DNA repair system benefit ...